Zhang H, Li X, Kan Y, Yang F, Hou Y, Du Y. Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease. Exp Ther Med. 2015;10:1925-1930 pubmed

Kostić I, Fidalgo Carvalho I, Aday S, Vazão H, Carvalheiro T, Grãos M, et al. Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions. Sci Rep. 2015;5:16406 pubmed publisher

Liang R, Camprecios G, Kou Y, McGrath K, Nowak R, Catherman S, et al. A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis. PLoS Genet. 2015;11:e1005526 pubmed publisher

Giampietro C, Deflorian G, Gallo S, di Matteo A, Pradella D, Bonomi S, et al. The alternative splicing factor Nova2 regulates vascular development and lumen formation. Nat Commun. 2015;6:8479 pubmed publisher

Noguchi T, Ohta S, Kakinoki R, Ikeguchi R, Kaizawa Y, Oda H, et al. The neuroprotective effect of erythropoietin on spinal motor neurons after nerve root avulsion injury in rats. Restor Neurol Neurosci. 2015;33:461-70 pubmed publisher

Li Y, Chen S, Chien C. Erythropoietin produced by genetic-modified NIH/3T3 fibroblasts enhances the survival of degenerating neurons. Brain Behav. 2015;5:e00356 pubmed publisher

Irrera N, Bitto A, Pizzino G, Vaccaro M, Squadrito F, Galeano M, et al. Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury. Biomed Res Int. 2015;2015:968927 pubmed publisher

Chen Y, Chou C, Sun C. Impairment of the Cellular Distribution and Stability of the Erythropoietin Receptor Through the Direct Targeting of Aristolochic Acid. Toxicol Sci. 2015;147:246-54 pubmed publisher

Thomas S, Fisher K, Snowden J, Danson S, Brown S, Zeidler M. Methotrexate Is a JAK/STAT Pathway Inhibitor. PLoS ONE. 2015;10:e0130078 pubmed publisher

Katakura F, Yabu T, Yamaguchi T, Miyamae J, Shirinashihama Y, Nakanishi T, et al. Exploring erythropoiesis of common carp (Cyprinus carpio) using an in vitro colony assay in the presence of recombinant carp kit ligand A and erythropoietin. Dev Comp Immunol. 2015;53:13-22 pubmed publisher

Wei J, Zhao J, Schrott V, Zhang Y, Gladwin M, BULLOCK G, et al. Red Blood Cells Store and Release Interleukin-33. J Investig Med. 2015;63:806-10 pubmed publisher

Kim Y, Kim H, Baek E, Kurita R, Cha H, Nakamura Y, et al. Rh D blood group conversion using transcription activator-like effector nucleases. Nat Commun. 2015;6:7451 pubmed publisher

Lee E, Kim M, Park B, Kim J, Choi G, Lee J, et al. Avoiding unnecessary blood transfusions in women with profound anaemia. Aust N Z J Obstet Gynaecol. 2015;55:262-7 pubmed publisher

Singh P, Devasahayam M, Devi S. Expression of GPI anchored human recombinant erythropoietin in CHO cells is devoid of glycosylation heterogeneity. Indian J Exp Biol. 2015;53:195-201 pubmed

Capitano M, Chitteti B, Cooper S, Srour E, Bartke A, Broxmeyer H. Ames hypopituitary dwarf mice demonstrate imbalanced myelopoiesis between bone marrow and spleen. Blood Cells Mol Dis. 2015;55:15-20 pubmed publisher

Li K, Cao R, Zhu X, Liu X, Li L, Cui S. Erythropoietin Attenuates the Apoptosis of Adult Neurons After Brachial Plexus Root Avulsion by Downregulating JNK Phosphorylation and c-Jun Expression and Inhibiting c-PARP Cleavage. J Mol Neurosci. 2015;56:917-925 pubmed publisher

Malik J, Getman M, Steiner L. Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation. Mol Cell Biol. 2015;35:2059-72 pubmed publisher

Kummalue T, Inoue T, Miura Y, Narusawa M, Inoue H, Komatsu N, et al. Ribosomal protein L11- and retinol dehydrogenase 11-induced erythroid proliferation without erythropoietin in UT-7/Epo erythroleukemic cells. Exp Hematol. 2015;43:414-423.e1 pubmed publisher

Lindahl K, Hörnfeld E, Stahle L, Carlsson T, Weiland O, Parke Å, et al. High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients. Ther Drug Monit. 2015;37:745-50 pubmed publisher

Caillaud C, Mechta M, Ainge H, Madsen A, Ruell P, Mas E, et al. Chronic erythropoietin treatment improves diet-induced glucose intolerance in rats. J Endocrinol. 2015;225:77-88 pubmed publisher

Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55:1644-54 pubmed publisher

Abbott A. Neuroscience: The brain, interrupted. Nature. 2015;518:24-6 pubmed publisher

Kawabata H, Uchiyama T, Sakamoto S, Kanda J, Oishi S, Fujii N, et al. A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression. Exp Hematol. 2015;43:404-413.e5 pubmed publisher

Harzallah A, Zouaghi K, Dridi A, Boubaker K, Beji S, Ayari M, et al. Therapeutic efficacy of a biosimilar epoetin alfa in hemodialysis patients. Saudi J Kidney Dis Transpl. 2015;26:78-82 pubmed

Rubab Z, Amin H, Abbas K, Hussain S, Ullah M, Mohsin S. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis. Saudi J Kidney Dis Transpl. 2015;26:19-25 pubmed

Palmer S, Saglimbene V, Mavridis D, Salanti G, Craig J, Tonelli M, et al. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev. 2014;:CD010590 pubmed publisher

Cherayil B. Response to comment on "Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota". J Immunol. 2014;193:5763 pubmed publisher

Laval M, Baldwin G, Shulkes A, Marshall K. Increased gastrin gene expression provides a physiological advantage to mice under hypoxic conditions. Am J Physiol Gastrointest Liver Physiol. 2015;308:G76-84 pubmed publisher

Cancarini A, Costagliola C, dell Omo R, Romano M, Morescalchi F, Agnifili L, et al. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy. Minerva Endocrinol. 2014;39:305-11 pubmed

Grasso G, Buemi M, Giambartino F. The role of erythropoietin in aneurysmal subarachnoid haemorrhage: from bench to bedside. Acta Neurochir Suppl. 2015;120:75-80 pubmed publisher

Li J, Hale J, Bhagia P, Xue F, Chen L, Jaffray J, et al. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood. 2014;124:3636-45 pubmed publisher

Langdon J, Barkataki S, Berger A, Cheadle C, Xue Q, Sung V, et al. RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice. Am J Hematol. 2015;90:8-14 pubmed publisher

Leuchter R, Gui L, Poncet A, Hagmann C, Lodygensky G, Martin E, et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA. 2014;312:817-24 pubmed publisher

Babushok D, Cardamone D, Rulander N, Master S, Hexner E. A common, under-recognized cause of elevated serum erythropoietin. Am J Med. 2014;127:e7-8 pubmed publisher

Salsbury G, Cambridge E, McIntyre Z, Arends M, Karp N, Isherwood C, et al. Disruption of the potassium channel regulatory subunit KCNE2 causes iron-deficient anemia. Exp Hematol. 2014;42:1053-8.e1 pubmed publisher

Shen W, Chung S, Irhimeh M, Li S, Lee S, Gillies M. Systemic administration of erythropoietin inhibits retinopathy in RCS rats. PLoS ONE. 2014;9:e104759 pubmed publisher

Johnson D, Pascoe E, Badve S, Dalziel K, Cass A, Clarke P, et al. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial. Am J Kidney Dis. 2015;65:49-57 pubmed publisher

Miskowiak K, Ehrenreich H, Christensen E, Kessing L, Vinberg M. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry. 2014;75:1347-55 pubmed publisher

Bennett C, Bian J. Erythropoiesis-stimulating agents and quality of life: personal journeys of a cancer survivor, oncologist, and two cancer health services researchers. Br J Cancer. 2014;111:421-3 pubmed publisher

Chu D, Jiménez Saiz R, Verschoor C, Walker T, Goncharova S, Llop Guevara A, et al. Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo. J Exp Med. 2014;211:1657-72 pubmed publisher

Detry M, Lewis R. The intention-to-treat principle: how to assess the true effect of choosing a medical treatment. JAMA. 2014;312:85-6 pubmed publisher

Robertson C, Hannay H, Yamal J, Gopinath S, Goodman J, Tilley B, et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;312:36-47 pubmed publisher

Maki K, Sasaki K, Nagata Y, Nagasawa F, Nakamura Y, Ogawa S, et al. Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome. Int J Hematol. 2014;100:361-9 pubmed publisher

Rineau E, Chaudet A, Carlier L, Bizot P, Lasocki S. Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery. Br J Anaesth. 2014;113:296-8 pubmed publisher

Shanmugam N, Trebicka E, Fu L, Shi H, Cherayil B. Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota. J Immunol. 2014;193:1398-407 pubmed publisher

Woo M, Hawkins M. Beyond erythropoiesis: emerging metabolic roles of erythropoietin. Diabetes. 2014;63:2229-31 pubmed publisher

Lamrani L, Lacout C, Ollivier V, Denis C, Gardiner E, Ho Tin Noe B, et al. Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm. Blood. 2014;124:1136-45 pubmed publisher

Berhane H, Shinde A, Kalash R, Xu K, Epperly M, Goff J, et al. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039. Radiat Res. 2014;182:35-49 pubmed publisher

Mustapha O, Oke B, Offen N, SIREN A, Olopade J. Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: a protective role for erythropoietin. Environ Toxicol Pharmacol. 2014;38:98-111 pubmed publisher

Hwang S, Lee S, Park S, Chitteti B, Srour E, Cooper S, et al. Nonmarrow hematopoiesis occurs in a hyaluronic-acid-rich node and duct system in mice. Stem Cells Dev. 2014;23:2661-71 pubmed publisher

Merino J, Bellver Landete V, Oset Gasque M, Cubelos B. CXCR4/CXCR7 molecular involvement in neuronal and neural progenitor migration: focus in CNS repair. J Cell Physiol. 2015;230:27-42 pubmed publisher

Krishnan M, Nissenson A. New alternatives in anemia treatment: biosimilars and HIF stabilizers. Nephrol News Issues. 2014;28:24-8 pubmed

Uziel O, Kanfer G, Beery E, Yelin D, Shepshelovich D, Bakhanashvili M, et al. The effects of erythropoietin signaling on telomerase regulation in non-erythroid malignant and non-malignant cells. Biochem Biophys Res Commun. 2014;450:274-82 pubmed publisher

Kautz L, Jung G, Valore E, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46:678-84 pubmed publisher

Weng T, Fu T, Wang C, Hsu C, Wang J. Activation of lymphocyte autophagy/apoptosis reflects haemodynamic inefficiency and functional aerobic impairment in patients with heart failure. Clin Sci (Lond). 2014;127:589-602 pubmed publisher

Jaspers A, Baron F, Willems E, Seidel L, Hafraoui K, Vanstraelen G, et al. Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial. Blood. 2014;124:33-41 pubmed publisher

Lestz R, Fivush B, Atkinson M. Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis. Pediatr Nephrol. 2014;29:2021-8 pubmed publisher

Mäenpää J, Puistola U, Riska H, Sintonen H, Saarni O, Juvonen E, et al. Impact of Epoetin-beta on anemia and health-related quality of life in cancer patients: a prospective observational study using the generic 15D instrument. Anticancer Res. 2014;34:2325-9 pubmed

Tsui A, Marsden P, Mazer C, Sled J, Lee K, Henkelman R, et al. Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia. Am J Physiol Regul Integr Comp Physiol. 2014;307:R13-25 pubmed publisher

Liu C, Liu C, Huang C, Lin J, Dai C, Liang C, et al. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial. Gut. 2015;64:303-11 pubmed publisher

Jin W, Ming X, Hou X, Zhu T, Yuan B, Wang J, et al. Protective effects of erythropoietin in traumatic spinal cord injury by inducing the Nrf2 signaling pathway activation. J Trauma Acute Care Surg. 2014;76:1228-34 pubmed publisher

Bu Y, Su F, Wang X, Gao H, Lei L, Chang N, et al. Protein tyrosine phosphatase PTPN9 regulates erythroid cell development through STAT3 dephosphorylation in zebrafish. J Cell Sci. 2014;127:2761-70 pubmed publisher

Stojanovic V, Vučković N, Barisic N, Srdić B, Doronjski A, Peco Antić A. Early biomarkers of renal injury and protective effect of erythropoietin on kidneys of asphyxiated newborn rats. Pediatr Res. 2014;76:11-6 pubmed publisher

Castelli R, Deliliers G, Colombo R, Moreo G, Gallipoli P, Pantaleo G. Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function. Ann Hematol. 2014;93:1523-9 pubmed publisher

Ratilal B, Arroja M, Rocha J, Fernandes A, Barateiro A, Brites D, et al. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion. J Neurosurg. 2014;121:55-62 pubmed publisher

Kim Y, Mungunsukh O, McCart E, Roehrich P, Yee D, Day R. Mechanism of erythropoietin regulation by angiotensin II. Mol Pharmacol. 2014;85:898-908 pubmed publisher

Suragani R, Cadena S, Cawley S, Sako D, Mitchell D, Li R, et al. Transforming growth factor-? superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014;20:408-14 pubmed publisher

Alnaeeli M, Raaka B, Gavrilova O, Teng R, Chanturiya T, Noguchi C. Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity. Diabetes. 2014;63:2415-31 pubmed publisher

Tatarelli C, Piccioni A, Maurillo L, Naso V, Battistini R, D Andrea M, et al. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study. Ann Hematol. 2014;93:1413-20 pubmed publisher

Barbosa C, Romão L. Translation of the human erythropoietin transcript is regulated by an upstream open reading frame in response to hypoxia. RNA. 2014;20:594-608 pubmed publisher

Aguilar C, Aguilar C, López Marure R, Jiménez Sánchez A, Rocha Zavaleta L. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2. Mol Med Rep. 2014;9:1895-902 pubmed publisher

Seed T, Inal C, Singh V. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. Int J Radiat Biol. 2014;90:594-604 pubmed publisher

Winkelmayer W, Mitani A, Goldstein B, Brookhart M, Chertow G. Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med. 2014;174:699-707 pubmed

Prica A, Buckstein R. Myelodysplastic syndrome successfully treated with adalimumab. J Clin Oncol. 2015;33:e4-6 pubmed publisher

Rölfing J, Jensen J, Jensen J, Greve A, Lysdahl H, Chen M, et al. A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs. Acta Orthop. 2014;85:201-9 pubmed publisher

Stoyanoff T, Todaro J, Aguirre M, Zimmermann M, Brandan N. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis. Toxicology. 2014;318:13-21 pubmed publisher

Slavova Azmanova N, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, et al. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival. Biochem J. 2014;459:455-66 pubmed publisher

Matsunawa M, Yamamoto R, Sanada M, Sato Otsubo A, Shiozawa Y, Yoshida K, et al. Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia. Leukemia. 2014;28:1844-50 pubmed publisher

Gardner D, Welham S, Dunford L, McCulloch T, Hodi Z, Sleeman P, et al. Remote conditioning or erythropoietin before surgery primes kidneys to clear ischemia-reperfusion-damaged cells: a renoprotective mechanism?. Am J Physiol Renal Physiol. 2014;306:F873-84 pubmed publisher

de Goeij M, Meuleman Y, van Dijk S, Grootendorst D, Dekker F, Halbesma N. Haemoglobin levels and health-related quality of life in young and elderly patients on specialized predialysis care. Nephrol Dial Transplant. 2014;29:1391-8 pubmed publisher

Barichello T, Simões L, Generoso J, Sangiogo G, Danielski L, Florentino D, et al. Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis. Transl Res. 2014;163:503-13 pubmed publisher

Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Ishibashi T, Sudo T, et al. The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis. Exp Hematol. 2014;42:410-422.e4 pubmed publisher

Dahmani O, Demarchi P, Sophoclis C, Abi Ayad K, Belkhalfa S, Djellid J. Recurrent epistaxis revealing a non-catheter-related superior vena cava syndrome in a hemodialysis patient: unmasking undifferentiated connective tissue disease. Saudi J Kidney Dis Transpl. 2014;25:117-20 pubmed

Mohammadpour A, Nazemian F, Khaiat M, Tafaghodi M, Salari P, Charkazi S, et al. Evaluation of the effect of pentoxifylline on erythropoietin-resistant anemia in hemodialysis patients. Saudi J Kidney Dis Transpl. 2014;25:73-8 pubmed

So Osman C, Nelissen R, Koopman van Gemert A, Kluyver E, Pöll R, Onstenk R, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 1. Anesthesiology. 2014;120:852-60 pubmed publisher

So Osman C, Nelissen R, Koopman van Gemert A, Kluyver E, Pöll R, Onstenk R, et al. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible pat. Anesthesiology. 2014;120:839-51 pubmed publisher

Liu X, Wu H. [Progress on neuroprotective effects of erythropoietin]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013;42:693-9 pubmed

Bahcekapili N, Akgun Dar K, Albeniz I, Kapucu A, Kandil A, Yağız O, et al. Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures. Int J Neurosci. 2014;124:762-70 pubmed publisher

McCarthy J, Hocum C, Albright R, Rogers J, Gallaher E, Steensma D, et al. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014;89:87-94 pubmed publisher

Wang P, Dong S, Shieh J, Peguero E, Hendrickson R, Moore M, et al. Erythropoietin derived by chemical synthesis. Science. 2013;342:1357-1360 pubmed publisher

Hsieh Wilson L, Griffin M. Chemistry. Improving biologic drugs via total chemical synthesis. Science. 2013;342:1332-3 pubmed publisher

Mohd Slim M, Shaik R. Pure red cell aplasia associated with recombinant erythropoietin: a case report and brief review of the literature. N Z Med J. 2013;126:106-10 pubmed

Weiner D, Winkelmayer W. Commentary on 'The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle': iron(y) abounds 2 years later. Am J Kidney Dis. 2013;62:1217-20 pubmed publisher

Kim S, Chin Y, Heo T. Erythropoietic agents from natural sources. Altern Ther Health Med. 2013;19:54-60 pubmed

Zahang X, Yu X, Huang Y. [Triggers, mechanisms, and potential clinical applications of cerebral ischemic tolerance]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35:567-70 pubmed publisher

Salomon Andonie J, Miasnikova G, Sergueeva A, Polyakova L, Niu X, Nekhai S, et al. Effect of congenital upregulation of hypoxia inducible factors on percentage of fetal hemoglobin in the blood. Blood. 2013;122:3088-9 pubmed publisher

Fuller D, Pisoni R, Bieber B, Port F, Robinson B. The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle. Am J Kidney Dis. 2013;62:1213-6 pubmed publisher

Bruhn C. [Patient blood management - fewer transfusions, lower costs]. Dtsch Med Wochenschr. 2013;138:1752 pubmed

Lin D, Lin E, Tran M. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev. 2013;27:221-34 pubmed publisher

Worthmann H, Kielstein J, Weissenborn K. Response to letter regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke". Stroke. 2013;44:e230 pubmed publisher

Kurtoglu E, Balta S, Sincer I, Korkmaz H. Letter by Kurtoglu et al regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke". Stroke. 2013;44:e229 pubmed publisher

Tahan F, Akar H, Dursun I, Yilmaz K. Desensitization of darbepoetin-α: a case report. Eur Ann Allergy Clin Immunol. 2013;45:176-7 pubmed

Wei X, Li Y, Sun X, Zhu X, Feng Y, Liu J, et al. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Infect Immun. 2014;82:165-73 pubmed publisher

Kapadia B, Banerjee S, Issa K, McElroy M, Harwin S, Mont M. Preoperative blood management strategies for total knee arthroplasty. J Knee Surg. 2013;26:373-7 pubmed publisher

de Araújo Azi L, Lopes F, Garcia L. Postoperative management of severe acute anemia in a Jehovah's Witness. Transfusion. 2014;54:1153-7 pubmed publisher

Bulut G, Sulahian R, Yao H, Huang L. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis. Blood. 2013;122:3964-72 pubmed publisher

Rodgers K, Espinoza T, Roda N, Meeks C, diZerega G. Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery. Cancer Chemother Pharmacol. 2013;72:1235-45 pubmed publisher

Cikrikcioglu M, Karatoprak C, Cakirca M, Kiskaç M, Zorlu M, Cetin G, et al. Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease. Eur Rev Med Pharmacol Sci. 2013;17:2530-7 pubmed

Kawakita M, MIYAKE T. [The legend of erythropoietin: from purification to molecular cloning]. Rinsho Ketsueki. 2013;54:1615-24 pubmed

Means R. Anemia of inflammation: clinical insights from mechanisms. Rinsho Ketsueki. 2013;54:1596-602 pubmed

Pol S. HCV, ribavirin, and anemia: a new dawn. Gastroenterology. 2013;145:930-3 pubmed publisher

Joshi D, Abraham D, Shiwen X, Baker D, Tsui J. Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia. J Vasc Surg. 2014;60:191-201, 201.e1-2 pubmed publisher

Ji J, Zhang J, Wang X, Mu Q, Fan M, Chen Y. [Effects of umbilical cord blood monocytes transplantation on EPO protein and oligodendrocyte progenitors in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo Dang Dai Er Ke Za Zhi. 2013;15:775-8 pubmed

Lundgrin E, Janocha A, Koch C, Gebremedhin A, Di Rienzo A, Alkorta Aranburu G, et al. Plasma hepcidin of Ethiopian highlanders with steady-state hypoxia. Blood. 2013;122:1989-91 pubmed publisher

Badve S, Beller E, Cass A, Francis D, Hawley C, Macdougall I, et al. Interventions for erythropoietin-resistant anaemia in dialysis patients. Cochrane Database Syst Rev. 2013;:CD006861 pubmed publisher

Neumann M. A star rises, another fades. Nephrol News Issues. 2013;27:8 pubmed

Sienas L, Wong T, Collins R, Smith J. Contemporary uses of erythropoietin in pregnancy: a literature review. Obstet Gynecol Surv. 2013;68:594-602 pubmed publisher

Karakas M, Koenig W. Darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;369:487 pubmed publisher

Swedberg K, McMurray J, Young J. Darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;369:488-9 pubmed publisher

Bartnicki P, Kowalczyk M, Rysz J. The influence of the pleiotropic action of erythropoietin and its derivatives on nephroprotection. Med Sci Monit. 2013;19:599-605 pubmed publisher

Dzgoeva F, Gatagonova T, Kadzaeva Z, Khamitsaeva O, Kochisova Z, Dzueva A, et al. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy]. Ter Arkh. 2013;85:44-50 pubmed

Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck H, du Bois A, et al. Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial. J Natl Cancer Inst. 2013;105:1018-26 pubmed publisher

Dang C, Hudis C, Norton L. Epoetin alfa: to give or not to give. J Natl Cancer Inst. 2013;105:1001-3 pubmed publisher

Leyland Jones B. Erythropoiesis stimulating agents: a personal journey. J Natl Cancer Inst. 2013;105:999-1001 pubmed publisher

Mariotti C, Nachbauer W, Panzeri M, Poewe W, Taroni F, Boesch S. Erythropoietin in Friedreich ataxia. J Neurochem. 2013;126 Suppl 1:80-7 pubmed publisher

Zager P, Meyer K, Ladik V, Paine S, Johnson D. Anemia management using computerized decision support. Nephrol News Issues. 2013;27:Supp 19-21 pubmed

Finkelstein F. How do we operationalize the individualization of ESA dosing and target Hb levels?. Nephrol News Issues. 2013;27:Supp 17-8 pubmed

Berns J. Is eliminating the floor for the Hb range consistent with patient-centered care?. Nephrol News Issues. 2013;27:Supp 15-6 pubmed

Fishbane S, Shah H. Choice of erythropoiesis stimulating agent in ESRD. Nephrol News Issues. 2013;27:Supp 10-2 pubmed

Beserab A. ESAs and irons in the pipeline: how do they differ?. Nephrol News Issues. 2013;27:Supp 6-9 pubmed

Szczech L. ESA dose vs. Hb levels: what needs to be monitored?. Nephrol News Issues. 2013;27:Supp 4-5, Supp 22 pubmed

Wish J. Management of anemia in patients with kidney disease in 2013 and beyond. Nephrol News Issues. 2013;27:Supp 1-3 pubmed

Ellis A, Brookhart M. Approaches to inverse-probability-of-treatment--weighted estimation with concurrent treatments. J Clin Epidemiol. 2013;66:S51-6 pubmed publisher

Al Saran K, Sabry A, Hassan A. Effect of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in chronic hemodialysis patients: a single Saudi center experience. Saudi J Kidney Dis Transpl. 2013;24:825-31 pubmed

Mastromarino V, Musumeci M, Conti E, Tocci G, Volpe M. Erythropoietin in cardiac disease: effective or harmful?. J Cardiovasc Med (Hagerstown). 2013;14:870-8 pubmed publisher

Bath P, Sprigg N, England T. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev. 2013;:CD005207 pubmed publisher

Ohls R, Christensen R, Kamath Rayne B, Rosenberg A, Wiedmeier S, Roohi M, et al. A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants. Pediatrics. 2013;132:e119-27 pubmed publisher

Wilson R, Dong S, Wang P, Danishefsky S. The winding pathway to erythropoietin along the chemistry-biology frontier: a success at last. Angew Chem Int Ed Engl. 2013;52:7646-65 pubmed publisher

Lenzer J. Why we can't trust clinical guidelines. BMJ. 2013;346:f3830 pubmed publisher

Trichonas G, Lee T, Hoppe G, Au J, Sears J. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model. Invest Ophthalmol Vis Sci. 2013;54:4919-26 pubmed publisher

Seibold N, Schild S, Gebhard M, Noack F, Schroder U, Rades D. Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck. Impact of tumor cell expression of EPO and EPO-R. Strahlenther Onkol. 2013;189:559-65 pubmed publisher

Roubille F, Prunier F, Barrère Lemaire S, Leclercq F, Piot C, Kritikou E, et al. What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials. Cardiovasc Drugs Ther. 2013;27:315-31 pubmed publisher

Slavova Azmanova N, Kucera N, Satiaputra J, Stone L, Magno A, Maxwell M, et al. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling. Blood. 2013;122:262-71 pubmed publisher

Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, et al. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab. Invest Ophthalmol Vis Sci. 2013;54:3874-9 pubmed publisher

Makarova N. [Methods for the correction of dysregulated erythropoesis in coronary heart disease]. Klin Med (Mosk). 2013;91:28-31 pubmed

Eyre T, Littlewood T. Anaemia in congestive heart failure. Br J Hosp Med (Lond). 2013;74:252-7 pubmed

Tan Q, Kerestes H, Percy M, Pietrofesa R, Chen L, Khurana T, et al. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J Biol Chem. 2013;288:17134-44 pubmed publisher

Günter C, Rezaeian F, Harder Y, Lohmeyer J, Egert S, Bader A, et al. [Erythropoietin in plastic surgery]. Handchir Mikrochir Plast Chir. 2013;45:108-19 pubmed publisher

Lynn S, McDaniel J. Managing severe anemia when the patient is a Jehovah's Witness. JAAPA. 2013;26:24, 27-9 pubmed

Hong P, Boyd D, Beyea S, Bezuhly M. Enhancement of bone consolidation in mandibular distraction osteogenesis: a contemporary review of experimental studies involving adjuvant therapies. J Plast Reconstr Aesthet Surg. 2013;66:883-95 pubmed publisher

Ney P. Another path to ERK activation. Blood. 2013;121:3064-5 pubmed publisher

Yeh P, Liao F, Lin S. Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?. J Formos Med Assoc. 2013;112:655-6 pubmed publisher

Kshirsagar A, Freburger J, Ellis A, Wang L, Winkelmayer W, Brookhart M. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med. 2013;126:541.e1-541.e14 pubmed publisher

Tomoda H. Peginesatide for anemia in chronic kidney disease. N Engl J Med. 2013;368:1553 pubmed publisher

Chong Z, Shang Y, Mu Y, Cui S, Yao Q, Maiese K. Targeting erythropoietin for chronic neurodegenerative diseases. Expert Opin Ther Targets. 2013;17:707-20 pubmed publisher

Bunn H. Erythropoietin. Cold Spring Harb Perspect Med. 2013;3:a011619 pubmed publisher

Cervellini I, Ghezzi P, Mengozzi M. Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis. Methods Mol Biol. 2013;982:163-73 pubmed publisher

Reichel C, Thevis M. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. Bioanalysis. 2013;5:587-602 pubmed publisher

Broxmeyer H. Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration. J Exp Med. 2013;210:205-8 pubmed publisher

Morais C, Johnson D, Vesey D, Gobe G. Functional significance of erythropoietin in renal cell carcinoma. BMC Cancer. 2013;13:14 pubmed publisher

Lomonosov M, Meziane E, Ye H, Nelson D, Randle S, Laman H. Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis. PLoS ONE. 2011;6:e21165 pubmed publisher